Monitoring of antibiotic consumption and development of resistance by enterobacteria in a tertiary care hospital

Journal of Clinical Pharmacy and Therapeutics

Volumn 40, Issue 4, 2015, Pages 426-430

  Veličković Radovanović, Radmila M ^a,b,d,e   Stefanovic N ^a   Damnjanovic I ^a   Kocic B ^a,c   Antic S ^c   Dinic M ^a,c   Petrovic J ^b   Mitic R ^b   Catic Djordjevic A ^a  

^a UNIVERSITY OF NI   (Serbia)

^b Clinical Centre Nis   (Serbia)

^c Institute for Public Health of Ni   (Serbia)

^d Clinical Centre   (Serbia)

^e NONE   (Serbia)

Author keywords

antibiotic consumption; bacterial resistance; ceftriaxone; cephalosporins; enterobacteria

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEFALEXIN; CEFAZOLIN; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFPROZIL; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; LINCOSAMIDE; LINEZOLID; MACROLIDE; METRONIDAZOLE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SURVEILLANCE PROGRAM; DRUG USE; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MORTALITY; NONHUMAN; PRESCRIPTION; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERBIA; SURGICAL PATIENT; TERTIARY CARE CENTER; TREND STUDY; UNIVERSITY HOSPITAL; DRUG EFFECTS;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; HUMANS; TERTIARY CARE CENTERS;

EID: 84936985441     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12283     Document Type: Article

References (23)

1. Arda B, Sipahi OR, Yamazhan T, et al,. Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance. J Infect, 2007; 55: 41-48.
2. Khadem TM, Dodds AE, Wrobel MJ, Brown J, Antimicrobial stewardship: a matter of process or outcome? Pharmacotherapy, 2012; 32: 688-706.
3. Salehifar E, Nasehi M, Eslami G, Sahraei S, Alizadeh Navaei R, Determination of antibiotics consumption in buali-sina pediatric hospital, sari 2010-2011. Iranian Journal of Pharmaceutical Research, 2014; 13: 995-1001.
4. Velickovic-Radovanovic R, Petrovic J, Kocic B, Antic S, Randelovic G,. Correlation between antibiotic consumption and bacterial resistance as quality indicator of proper use of these drugs in inpatients. Vojnosanit Pregl, 2009; 66: 307-312.
5. Cizman M,. The use and resistance to antibiotics in the community. Int J Antimicrob Agents, 2003; 21: 297-307.
6. Solomkin JS, Mazuski JE, Bradley JS, et al,. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis, 2010; 50: 133-164.
7. Paterson DL, Rossi F, Baquero F, et al,. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother, 2005; 55: 965-973.
8. Arnold SR, Straus SE, Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database of Systematic Reviews, 2005; 4: CD003539.
9. WHO Global Strategy for Containment of Antimicrobial Resistance. [Internet]. Geneva: World Health Organization; 2001 [cited 2014 November 20]. Available from: http://www.who.int/drugresistance/WHO-Global-Strategy-English.pdf
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. Wayne, PA: National Committee for Clinical Laboratory Standards; 2007.
11. Chaouch C, Hassairi A, Riba M, Boujaafar N,. Association between bacterial resistance and antimicrobial consumption. Ann Biol Clin, 2014; 72: 555-560.
12. Borde JP, Kaier K, Steib-Bauert M, et al,. Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center. BMC Infect Dis, 2014; 14: 201.
13. Versporten A, Bolokhovets G, Ghazaryan L, et al,. Antibiotic use in Eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect Dis, 2014; 14: 381-387.
14. Keuleyan E, Kirov G, Kondarev M, et al,. Surgical personnel' adherence to antibiotic policies. Journal of IMAB, 2010; 16: 83-89.
15. Ion-Nedelcu N, Radu L, Firulescu S, et al,. Use of systemic antibacterial agents at a university emergency clinic in Bucharest, in the year 2008. Bacteriol Virusol Parazitol Epidemiol, 2009; 54: 53-58.
16. Blommaert A, Coenen S, Gielen B, Goossens H, Hens N, Beutels P,. Patient and prescriber determinants for the choice between amoxicillin and broader-spectrum antibiotics: a nationwide prescription-level analysis. J Antimicrob Chemother, 2013; 68: 2383-2392.
17. Harbarth S, Albrich W, Brun-Buisson C,. Outpatient antibiotic use and prevalence of antibiotic-resistance pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis, 2002; 8: 654-661.
18. Velickovic-Radovanovic R, Petrovic J, Kocic B, Antic S, Mitic R,. Analysis of antibiotic utilization and bacterial resistance changes in a surgical clinic of Clinical Centre, Nis. J Clin Pharm Ther, 2012; 37: 32-36.
19. Paterson DL,. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control, 2006; 34 (5 Suppl 1): S20-S28.
20. Sedláková MH, Urbánek K, Vojtová V, Suchánková H, Imwensi P, Kolář M,. Antibiotic consumption and its influence on the resistance in Enterobacteriaceae. BMC Research Notes, 2014; 7: 454.
21. Bosso JA, Mauldin PD, Salgado CD,. The association between antibiotic use and resistance: the role of secondary antibiotics. Eur J Clin Microbiol Infect Dis, 2010; 29: 1125-1129.
22. Meyer E, Lapatschek M, Bechtold A, Schwarzkopf G, Gastmeier P, Schwab F,. Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU. Intensive Care Med, 2009; 35: 862-870.
23. Arnan M, Gudiol C, Calatayud L, et al,. Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis, 2011; 30: 355-360.